A Phase I Investigation of the Intravenous Administration of AGS-1C4D4 in Patients With Advanced Hormone Refractory Prostate Cancer.
Phase of Trial: Phase I
Latest Information Update: 18 Jun 2014
At a glance
- Drugs Anti-PSCA monoclonal antibody (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- Sponsors Astellas Pharma
- 18 Dec 2009 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
- 18 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Sep 2009 Planned end date changed from 1 Aug 2008 to 1 Nov 2009 as reported by ClinicalTrials.gov.